Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Boston Scientific Corp (BSX) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 34,573,056
  • Shares Outstanding, K 1,361,680
  • Annual Sales, $ 8,386 M
  • Annual Income, $ 347 M
  • 36-Month Beta 1.06
  • Price/Sales 4.12
  • Price/Book 5.13

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.39 +8.55%
on 01/26/17
25.65 -1.01%
on 02/15/17
+1.49 (+6.23%)
since 01/17/17
3-Month
19.67 +29.08%
on 12/01/16
25.65 -1.01%
on 02/15/17
+3.78 (+17.49%)
since 11/17/16
52-Week
16.82 +50.95%
on 03/01/16
25.65 -1.01%
on 02/15/17
+7.82 (+44.51%)
since 02/17/16

Most Recent Stories

More News
Drug-Eluting Stents Market 2015-2022 - Global Strategic Business Report 2017 with Abbott Laboratories, Boston Scientific & Medtronic Leading - Research and Markets

Research and Markets has announced the addition of the "Drug-Eluting Stents - Global Strategic Business Report" report to their offering.

BSX : 25.39 (+0.12%)
MDT : 78.88 (+1.14%)
$95.71 Billion Wearable Computing Market - Forecasts from 2016 to 2021: Key Players are Garmin, Boston Scientific Corporation, Adidas, Apple, Fitbit, Jawbone - Research and Markets

Research and Markets has announced the addition of the "Wearable Computing Market - Forecasts from 2016 to 2021" report to their offering.

BSX : 25.39 (+0.12%)
Global Endometrial Ablation Market to Reach US$1.3 Billion by 2024: Radiofrequency Endometrial Ablation Devices to Remain Most Preferred Product, Predicts TMR

With the presence of large players, such as Hologic Corp., Boston Scientific Corp., Cooper Surgical Inc., Ethicon Inc., and Medtronic Plc at the global level, the worldwide market for Endometrial Ablation...

BSX : 25.39 (+0.12%)
Global Endoscopy Systems Industry

This report analyzes the worldwide markets for Endoscopy Systems in US$ Thousand by the following Product Segments: Endoscopes, and Visualization Equipment. The report provides separate comprehensive analytics...

BSX : 25.39 (+0.12%)
Schwab, Ralph Lauren fall; Mead Johnson, Entercom gain

NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday:

DLPH : 75.46 (+0.32%)
MJN : 87.50 (-0.11%)
R : 77.17 (-0.13%)
BSX : 25.39 (+0.12%)
MRK : 65.39 (+0.20%)
RL : 78.39 (-0.10%)
ETM : 15.50 (+3.33%)
Boston Scientific (BSX) Tops Q4 Earnings, Offers 2017 View

Boston Scientific Corporation (BSX) posted adjusted earnings per share (EPS) of 30 cents, up 15.4% from the year-ago adjusted number.

BSX : 25.39 (+0.12%)
GKOS : 45.62 (+0.40%)
NEOG : 65.93 (+0.95%)
CSII : 29.19 (+2.67%)
Boston Scientific (BSX) Beats on Earnings & Revenues in Q4

Boston Scientific (BSX) has posted positive results with both its top line and bottom line beating the Zacks Consensus Estimate.

BSX : 25.39 (+0.12%)
5 Stocks with Spectacular Earnings Charts

These 5 companies have perfect earnings beat records for the last 5 years.

MMC : 73.52 (+0.35%)
AOS : 49.59 (-0.18%)
BSX : 25.39 (+0.12%)
V : 87.46 (+0.06%)
SNA : 172.57 (-0.43%)
FB : 133.53 (-0.23%)
Medical Product Earnings Due on Feb 2: BDX, BSX, IDXX, ATHN

The medical sector is likely to see 2.9% earnings growth on 5.7% higher revenues in the quarter.

BSX : 25.39 (+0.12%)
ATHN : 118.96 (+1.73%)
BDX : 180.90 (+0.16%)
IDXX : 142.23 (+0.20%)
Research and Markets - Global Left Atrial Appendage Closure Market Growth at CAGR of 33.54% by 2021, with AtriCure, Boston Scientific, Coherex Medical & St. Jude Medical Dominating

Research and Markets has announced the addition of the "Global Left Atrial Appendage Closure Market 2017-2021" report to their offering.

BSX : 25.39 (+0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary...

See More

Support & Resistance

2nd Resistance Point 25.56
1st Resistance Point 25.47
Last Price 25.39
1st Support Level 25.23
2nd Support Level 25.08

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.